News

The FDA has approved a new pneumococcal vaccine from Merck & Co, just over a month after Pfizer got a green light for a new version of its market leading Prevnar shot. Merck's Vaxneuvance ...
Send in your questions here. End of carousel The FDA was on track to grant full approval for the vaccine April 1, according to two people familiar with the matter who spoke on the condition of ...
Despite indications that a single dose of Merck's (NYSE:MRK) human papillomavirus vaccine Gardasil could be as effective as ...
Expert advisors for the Food and Drug Administration met Thursday to discuss which virus strain this year's updated COVID-19 ...